BDgene

Study Report

Basic Info
Reference
Citation Martucci, L., A. H. Wong, et al. (2006). "N-methyl-D-aspartate receptor NR2B subunit gene GRIN2B in schizophrenia and bipolar disorder: Polymorphisms and mRNA levels." Schizophr Res 84(2-3): 214-221.
Disease Type Bipolar Disorder & Schizophrenia
Study Design case-control and family-based
Study Type Candidate-gene association study
Sample Size 180 matched schizophrenia case-control pairs, 86 schizophrenia nuclear family trios and 318 bipolar disorder trios
SNP/Region/Marker Size 3 SNPs
Predominant Ethnicity Caucasian
Population Canadian
Gender male/female ratio is 1: 1.11 of the schizophrenia sample, the male/female ratio is 1: 0.85 of the bipolar trio sample
Age Group adults : The average age was 37 years of the schizophrenia sample, the average age of the probands was 41 years of the bipolar trio sample

Detail Info

Genetic factors reported by this study for BD
Haplotypes reported by this study for BD (count: 6)

Other variants reported by this study for BD (count: 3)

Genes reported by this study for BD (count: 1)

Genetic factors reported by this study for SZ and/or MDD
Haplotypes reported by this study for SZ/MDD
Disease Markers Haplotype Related Gene(s)/Region(s) Statistical Values Description Result Category
SZ GRIN2B_T200G - GRIN2B_A5806C - GRIN2B_T5988C T-C-T GRIN2B P-value = 0.102451, Z=-1.633 in schizophrenia family sample; P-value = 0.271 in schizophrenia case-controls sample The overall difference in haplotype transmission between cases and controls is statistically significant (p =0.005). Negative
SZ GRIN2B_T200G - GRIN2B_A5806C - GRIN2B_T5988C G-A-C GRIN2B P-value = 0.324213, Z=0.986 in schizophrenia family sample; P-value = 0.013 in schizophrenia case-controls sample The overall difference in haplotype transmission between cases and controls is statistically significant (p =0.005). Negative
SZ GRIN2B_T200G - GRIN2B_A5806C - GRIN2B_T5988C G-C-T GRIN2B P-value = 0.995395, Z=0.006 in schizophrenia family sample; P-value = 0.008 in schizophrenia case-controls sample Haplotype analyses on the schizophrenia case-control sample also showed significant elevation in the frequency of haplotype G-C-T in schizophrenia, and T-C-C in controls. The overall difference in haplotype transmission between cases and controls is statistically significant (p =0.005). Positive
SZ GRIN2B_T200G - GRIN2B_A5806C - GRIN2B_T5988C T-C-C GRIN2B P-value = 0.97519, Z=-0.031 in schizophrenia family sample; P-value = 0.01 in schizophrenia case-controls sample Haplotype analyses on the schizophrenia case-control sample also showed significant elevation in the frequency of haplotype G-C-T in schizophrenia, and T-C-C in controls. The overall difference in haplotype transmission between cases and controls is statistically significant (p =0.005). Positive
SZ GRIN2B_T200G - GRIN2B_A5806C - GRIN2B_T5988C G-C-C GRIN2B P-value = 0.650714, Z=-0.453 in schizophrenia family sample; P-value = 0.104 in schizophrenia case-controls sample The overall difference in haplotype transmission between cases and controls is statistically significant (p =0.005). Negative
SZ GRIN2B_T200G - GRIN2B_A5806C - GRIN2B_T5988C T-A-C GRIN2B P-value = 0.242452, Z=1.169 in schizophrenia family sample; P-value = 0.116 in schizophrenia case-controls sample The overall difference in haplotype transmission between cases and controls is statistically significant (p =0.005). Negative

Other variants reported by this study for SZ/MDD
Disease Variant Name Related Gene Type Statistical Values Description Result Category
SZ GRIN2B -200G/T GRIN2B point mutation P-value (corrected)=0.0003, X2=17.974, df=2 of allele frequencies and association analysis in the schizophrenia case-control sample; case-control P-value < 0.0001, corrected for multiple testing P-value = 0.0003, case-control+triad P-value = 0.0009 of G/G genotype for the combined family and case-control schizophrenia samples; case-control P-value < 0.0001, corrected for multiple testing P-value = 0.0003, case-control+triad P-value = 0.0027 of G allele for the combined family and case-control schizophrenia samples; FBAT P-value = 0.44, z=0.775 in SCZ triads For the T-200G polymorphism, there was a statistically significant association between the G allele with schizophrenia in the case-control sample; for the G/G genotype as well as for the presence of the G allele. The result is still statistically significant after correcting for multiple testing. The nuclear families were tested for association using FBAT, showing no preferential transmission of either allele. Combining the z scores from the nuclear families and the case-control, we obtained an overall statistically significant result. Positive
SZ GRIN2B A5806C GRIN2B point mutation P-value (corrected)=0.305, X2=2.373, df=2 of allele frequencies and association analysis in the schizophrenia case-control sample; FBAT P-value = 0.73, z=0.349 in SCZ triads No association was found between the A5806C polymorphism and either schizophrenia or bipolar disorder (both families and case-control). Negative
SZ GRIN2B T5988C GRIN2B point mutation P-value (corrected)=0.654, X2=0.849, df=2 of allele frequencies and association analysis in the schizophrenia case-control sample; FBAT P-value = 0.56, z=0.6 in SCZ triads The T5988C polymorphism was not associated with schizophrenia in either sample. Negative

Genes reported by this study for SZ/MDD
Disease Gene Description Result Category
SZ GRIN2B GRIN2B expression levels in schizophrenia, bipolar disorder and controls were not significantly different. The genetic findings suggest a role for GRIN2B in schizophrenia and bipolar disorder. Positive